Not logged in Share Save
NAVIG-1: A PHASE I/IIA STUDY EVALUATING AN ANTI-TELOMERASE IMMUNOTHERAPY IN GLIOBLASTOMA Cuzzubbo, S.; Roch, B.; Gautrais, A.; Khacef, K.; Samai, H. C.; Osswald, E.; Belin, C.; Barsan, C.; Ursu, R.; Crainic, N.; Abi Jaoude, S.; Bourdillon, P.; Banissi, C.; Carpentier, A. F. Share Save
A PHASE II STUDY OF AN ANTI-TERT VACCINE (UCPVAX) WITH OR WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA Carpentier, A. F.; Cuzzubbo, S.; Verlut, C.; Meurisse, A.; Fumet, J.; Boullerot, L.; Bronnimann, C.; Tabouret, E.; Ursu, R.; Barsan, C.; Belin, C.; Jacquin, M.; Moltenis, M.; Kroemer, M.; Fagnoni-Legat, C.; Ghiringhelli, F.; Vernerey, D.; Laheurte, C.; Adotevi, O. Share Save
Share Save
CAN COGNITIVE PERFORMANCE PREDICT NEUROTOXICITY INCIDENCE FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR LYMPHOMA? Ursu, R.; Barsan, C.; Belin, C.; Cuzzubbo, S.; Carreau, C.; El Soudany, M.; Sivapragassame, R.; Cristinelli, C.; Di Blasi, R.; Ouedrani, A.; Caillat-Zucman, S.; Thieblemont, C.; Carpentier, A. Share Save
Prognosis of glioblastoma patients improves significantly over time interrogating historical controls Thomas-Joulie, A.; Tran, S.; El Houari, L.; Seyve, A.; Bielle, F.; Birzu, C.; Lozano-Sanchez, F.; Mokhtari, K.; Giry, M.; Marie, Y.; Laigle-Donadey, F.; Dehais, C.; Houillier, C.; Psimaras, D.; Alentorn, A.; Laurenge, A.; Touat, M.; Sanson, M.; Hoang-Xuan, K.; Kas, A.; Rozenblum, L.; Habert; Nichelli, L.; Leclercq, D.; Galanaud, D.; Jacob, J.; Karachi, C.; Capelle, L.; Carpentier, A.; Mathon, B.; Belin, L.; Idbaih, A. Share Save
UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM Carpentier, A. F.; Verlut, C.; Ghiringhelli, F.; Bronnimann, C.; Ursu, R.; Fumet, J.; Gherga, E.; Lefort, F.; Belin, C.; Vernerey, D.; Larroquette, M. Mathieu; Hervieu, A.; Laheurte, C.; Meurisse, A.; Jacquin, M.; Malfroy, M.; Kroemer, M.; Clairet, A.; Fagnoni-Legat, C.; Lehmann-Che, J.; Boullerot, L.; Cuzzubbo, S.; Adotevi, O. Share Save
LONG-TERM SURVIVAL WITH IDH WILDTYPE GLIOBLASTOMA: FIRST RESULTS FROM THE ETERNITY BRAIN TUMOR FUNDERS' COLLABORATIVE CONSORTIUM (EORTC 1419) Weller, M.; Felsberg, J.; Gramatzki, D.; Le Rhun, E.; Clarke, J.; Soffietti, R.; Wick, W.; Chinot, O.; Ducray, F.; Roth, P.; McDonald, K.; Hau, P.; Hottinger, A. F.; Reijneveld, J.; Schnell, O.; Marosi, C.; Glantz, M.; Darlix, A.; Lombardi, G.; Krex, D.; Glas, M.; Reardon, D. A.; van den Bent, M. J.; Lefranc, F.; Herrlinger, U.; Razis, E.; Carpentier, A. F.; Phillips, S.; Ruda, R.; Wick, A.; Tabouret, E.; Meyronet, D.; Maurage, C.; Rushing, E.; Rapkins, R. Share Save
ANALYSIS OF RNA CLASSIFIES NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS AND IDENTIFIES PATIENTS VULNERABLE TO TARGETED METABOLIC THERAPIES Di Stefano, A.; Picca, A.; Garofano, L.; Lerond, J.; Bielle, F.; Ducray, F.; Chinot, O.; Carpentier, A.; Younan, N.; Eoli, M.; Santonocito, O.; Mazzanti, C.; Lasorella, A.; Iavarone, A.; Sanson, M. Share Save
A threshold of mitotic activity and post-surgery residual volume are independant prognostic factors in astrocytoma IDH-mutant Tran, S.; Thomas, A.; Touat, M.; Karachi, C.; Lozano, F.; Mokhtari, K.; Dehais, C.; Feuvret, L.; Carpentier, C.; Giry, M.; Doukani, H.; Lerond, J.; Marie, Y.; Sanson, M.; Idbaih, A.; Carpentier, A.; Hoang-Xuan, K.; Capelle, L.; Bielle, F. Share Save
Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic Lozano-Sanchez, Fernando; Ursu, Renata; Di-Stefano, Anna Luisa; Ducray, Francois; Younan, Nadia; Touat, Mehdi; Groh, Matthieu; Agguini, Hanane; Belin, Catherine; Garnier, Luois; Delattre, Jean-Yves; Carpentier, Antoine; Idbaih, Ahmed Share Save
Description of neurotoxicity in a series of patients treated with CAR T-cell therapy Belin, Catherine; Devic, Perrine; Ayrignac, Xavier; Dos Santos, Amelie; Paix, Adrien; Sirven-Villaros, Lila; Simard, Claire; Lamure, Sylvain; Gastinne, Thomas; Ursu, Renata; Berger, Colette; Platon, Laura; Tessoulin, Benoit; Azoulay, Elie; Wallet, Florent; Thieblemont, Catherine; Bachy, Emmanuel; Cartron, Guillaume; Laplaud, David A.; Carpentier, Antoine F. Share Save
CMV REACTIVATION IN A COHORT OF NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH TEMOZOLOMIDE CHEMORADIOTHERAPY. A SINGLE CENTER ANALYSIS Ursu, R.; Doridam, J.; Chaugne, E.; Zannou, H.; Belin, C.; Cuzzubbo, S.; Sirven-Villaros, L.; Brichler, S.; Levy-Piedbois, C.; Carpentier, A. Share Save
NEUROLOGICAL FOLLOW-UP OF NEUROTOXICITY AFTER CAR T CELL THERAPY IN LYMPHOMA PATIENTS: A FRENCH NEUROLOGICAL MULTI-CENTER SURVEY Belin, C.; Simard, C.; Dos Santos, A.; Ayrignac, X.; Berger, C.; Cartron, G.; Le Gouill, S.; Sesques, P.; Thieblemont, C.; Carpentier, A. F. Share Save
Share Save
CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS Touat, M.; Li, Y.; Boynton, A.; Spurr, L.; Iorglescu, B.; Geduldig, J.; Birzu, C.; Fat, M. Lim; Santagata, S.; Coulet, F.; Beuvon, F.; Mokhtari, K.; Giry, M.; Block, S.; Guillerm, E.; Carpentier, A.; Huang, R.; Delattre, J.; Hoang-Xuan, K.; Sanson, M.; Duval, A.; Cherniack, A.; Reardon, D.; Wen, P.; Idbaih, A.; Marabelle, A.; Bandopadhayay, P.; Beroukhim, R.; Bielle, F.; Ligon, K. Share Save
People's corner: Pedro Brugada & Peter Schwartz share award Alto, Kari; Carpentier, Alain; de Gaetano, Giovanni; Gros, Francois; Haissaguerre, Michel; Lazdunski, Michel; Nemer, Mona; Noble, Denis; Sabatini, David D.; Samuelsson, Bengt; Taylor, Doris A. Share Save
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas Appay, Romain; Dehais, Caroline; Maurage, Claude-Alain; Alentorn, Agusti; Carpentier, Catherine; Colin, Carole; Ducray, Francois; Escande, Fabienne; Idbaih, Ahmed; Kamoun, Aurelie; Marie, Yannick; Mokhtari, Karima; Tabouret, Emeline; Trabelsi, Nesrine; Uro-Coste, Emmanuelle; Delattre, Jean-Yves; Figarella-Branger, Dominique; Desenclos, C.; Sevestre, H.; Menei, P.; Rousseau, A.; Cruel, T.; Lopez, S.; Mihai, M-I.; Petit, A.; Adam, C.; Parker, F.; Dam-Hieu, P.; Quintin-Roue, I.; Eimer, S.; Loiseau, H.; Bekaert, L.; Chapon, F.; Ricard, D.; Godfraind, C.; Khallil, T.; Cazals-Hatem, D.; Faillot, T.; Gaultier, C.; Tortel, M. C.; Carpiuc, I.; Richard, P.; Lahiani, W.; Aubriot-Lorton, H.; Ghiringhelli, F.; Maurage, C. A.; Ramirez, C.; Gueye, E. M.; Labrousse, F.; Chinot, O.; Bauchet, L.; Rigau, V.; Beauchesne, P.; Gauchotte, G.; Campone, M.; Loussouarn, D.; Fontaine, D.; Vandenbos-Burel, F.; Le Floch, A.; Roger, P.; Blechet, C.; Fesneau, M.; Carpentier, A.; Delattre, J. Y.; Elouadhani-Hamdi, S.; Polivka, M.; Larrieu-Ciron, D.; Milin, S.; Colin, P.; Diebold, M. D.; Chiforeanu, D.; Vauleon, E.; Langlois, O.; Laquerriere, A.; Forest, F.; Motso-Fotso, M. J.; Andraud, M.; Runavot, G.; Lhermitte, B.; Noel, G.; Gaillard, S.; Villa, C.; Desse, N.; Rousselot-Denis, C.; Zemmoura, I.; Cohen-Moyal, E.; Uro-Coste, E.; Dhermain, F. Share Save
Angiotensin II receptor blockers, steroids and radiotherapy in glioblastoma-a randomised multicentre trial (ASTER trial). An ANOCEF study Ursu, R.; Thomas, L.; Psimaras, D.; Chinot, O.; Le Rhun, E.; Ricard, D.; Charissoux, M.; Cuzzubbo, S.; Sejalon, F.; Quillien, V; Hoang-Xuan, K.; Ducray, F.; Portal, J-J; Tibi, A.; Mandonnet, E.; Levy-Piedbois, C.; Vicaut, E.; Carpentier, A. F. Share Save
The Cape Town Declaration on Access to Cardiac Surgery in the Developing World Zilla, Peter; Bolman, R. Morton; Yacoub, Magdi H.; Beyersdorf, Friedhelm; Sliwa, Karen; Zuhlke, Liesl; Higgins, Robert S. D.; Mayosi, Bongani; Carpentier, Alain; Williams, David Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}